Clinique UK ads
This article was originally published in The Rose Sheet
Executive Summary
Estee Lauder's Clinique division should not repeat an unsupported magazine advertising claim for Clinique Repairwear, the British Advertising Standards Authority concludes in a case reported on its Web site Oct. 11. The claim in question, "Enables skin to steer hearty cells to the base of a wrinkle and triggers skin's own natural collagen production," was not supported by studies submitted by Clinique, ASA concludes after hiring an independent expert to evaluate the research. "The expert questioned the implication that a topical product could suppress the local immune cells and either turn on collagen production, or increase it," the industry watchdog group says. Separately in the review, Clinique was able to support the ad claim "Creates a visible reduction in the appearance of wrinkles..".
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.